ARCHIVED – This event took place in 2014 and the content has not been updated since then. Some information may be out of date and links to other documents or websites may not work.
The meeting began with an update from the CQC on Controlled Drugs. The requirements for WDL and CD Licences were explored.
The NHS Trust Development Authority showed us how to develop a strategy for Medicines Optimisation in Community Health Services.
NHS England gave an update and Quality Premiums, Patient Safety Collaboratives and Medication Safety Officers were discussed.
Associate Director, Medicines Use and Safety Team